• 1
    Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345:4152.
  • 2
    Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002; 36(Suppl. 1):S3546.
  • 3
    Shiffman ML. Optimizing the current therapy for chronic hepatitis C virus: peginterferon and ribavirin dosing and the utility of growth factors. Clin Liver Dis 2008; 12:487505.
  • 4
    Dinarello CA. IL-18: a Th1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 1999; 103:1124.
  • 5
    Okamura H, Tsutsui H, Komatsu T et al. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 1995; 378:8891.
  • 6
    Tsutsui H, Matsui K, Kawada N, Hyodo Y, Hayashi N, Okamura H, Higashino K, Nakanishi K. IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J Immunol 1997; 159:39617.
  • 7
    Dao T, Mehal WZ, Crispe IN. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells. J Immunol 1998; 161:221722.
  • 8
    Tsutsui H, Nakanishi K, Matsui K, Higashino K, Okamura H, Miyazawa Y, Kaneda K. IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J Immunol 1996; 157:396773.
  • 9
    Fujioka N, Akazawa R, Ohashi K, Fujii M, Ikeda M, Kurimoto M. Interleukin-18 protects mice against acute herpes simplex virus type 1 infection. J Virol 1999; 73:24019.
  • 10
    Tanaka-Kataoka M, Kunikata T, Takayama S, Iwaki K, Ohashi K, Ikeda M, Kurimoto M. In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection. Cytokine 1999; 11:5939.
  • 11
    Choi HJ, Dinarello CA, Shapiro L. Interleukin-18 inhibits human immunodeficiency virus type 1 production in peripheral blood mononuclear cells. J Infect Dis 2001; 184:5608.
  • 12
    Kimura K, Kakimi K, Wieland S, Guidotti LG, Chisari FV. Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. J Virol 2002; 76:107027.
  • 13
    McGuinness PH, Painter D, Davies S, McCaughan GW. Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection. Gut 2000; 46:2609.
  • 14
    Abbate I, Romano M, Longo R et al. Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients. J Med Virol 2003; 70:5817.
  • 15
    Ludwiczek O, Kaser A, Novick D, Dinarello CA, Rubinstein M, Vogel W, Tilg H. Plasma levels of interleukin-18 and interleukin-18 binding protein are elevated in patients with chronic liver disease. J Clin Immunol 2002; 22:3317.
  • 16
    Chan SW, McOmish F, Holmes EC, Dow B, Peutherer JF, Follett E, Yap PL, Simmonds P. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol 1992; 73:113141.
  • 17
    Cramp ME, Carucci P, Rossol S, Chokshi S, Maertens G, Williams R, Naoumov NV. Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia. Gut 1999; 44:4249.
  • 18
    Chomcznski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate–phenol–chloroform extraction. Anal Biochem 1987; 162:1569.
  • 19
    Hanck C, Manigold T, Bocker U, Kurimoto M, Kolbel CB, Singer MV, Rossol S. Gene expression of interleukin 18 in unstimulated peripheral blood mononuclear cells of patients with alcoholic cirrhosis. Gut 2001; 49:10611.
  • 20
    Ishak K, Baptista A, Bianchi L et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22:6969.
  • 21
    Muhl H, Kampfer H, Bosmann M, Frank S, Radeke H, Pfeilschifter J. Interferon-gamma mediates gene expression of IL-18 binding protein in nonleukocytic cells. Biochem Biophys Res Commun 2000; 267:9603.
  • 22
    Paulukat J, Bosmann M, Nold M et al. Expression and release of Il-18 binding protein in response to IFN-gamma. J Immunol 2001; 167:703843.
  • 23
    Hongyu J, Jie D, Sihe Z, Yingji M, Huafeng C. Clinical observation of serum IL-18, IL-10 and sIL-2R levels in patients with chronic hepatitis C pre- and post antiviral treatment. Chin Med J 2003; 116:6058.
  • 24
    Tamura K, Fukuda H, Sashio H et al. IL18 polymorphism is associated with an increased risk of Crohn’s disease. J Gastroenterol 2002; 37:1116.
  • 25
    Zhang PA, Wu JM, Li Y, Yang XS. Association of polymorphisms of interleukin-18 gene promoter region with chronic hepatitis B in Chinese Han population. World J Gastroenterol 2005; 11:15948.
  • 26
    Giedraitis V, He B, Huang WX, Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 2001; 112:14652.
  • 27
    Hirankarn N, Manonom C, Tangkijvanich P, Poovorawan Y. Association of interleukin-18 gene polymorphism (−607A/A genotype) with susceptibility to chronic hepatitis B virus infection. Tissue Antigens 2007; 70:1603.
  • 28
    Bouzgarrou N, Hassen E, Schvoerer E et al. Association of IL-18 polymorphisms and plasma level with the outcome of chronic HCV infection. J Med Virol 2008; 80:60714.
  • 29
    Schvoerer E, Navas MC, Thumann C, Fuchs A, Meyer N, Habersetzer F, Stoll-Keller F. Production of interleukin-18 and interleukin-12 in patients suffering from chronic hepatitis C virus infection before antiviral therapy. J Med Virol 2003; 70:58893.
  • 30
    Micallef MJ, Yoshida K, Kawai S et al. In vivo antitumor effects of murine interferon-γ-inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites. Cancer Immunol Immunother 1997; 43:3617.
  • 31
    Jianhang L, Lihuang Z, Hangping Y, Xuetao C. Antitumor effects of interleukin-18 gene-modified hepatocyte cell line on implanted liver carcinoma. Chin Med J 2003; 116:14759.
  • 32
    Abiru S, Kato Y, Hamasaki K, Nakao K, Nakata K, Eguchi K. Spontaneous regression of hepatocellular carcinoma associated with elevated levels of interleukin 18. Am J Gastroenterol 2002; 97:7745.
  • 33
    Mihm S, Schweyer S, Ramadori G. Expression of the chemokine IP-10 correlates with the accumulation of hepatic IFN-γ and IL-18 mRNA in chronic hepatitis C but not in hepatitis B. J Med Virol 2003; 70:56270.
  • 34
    Ghayur T, Banerjee S, Hugunin M et al. Caspase-1 processes IFN-γ- inducing factor and regulates LPS-induced IFN-γ production. Nature 1997; 386:61923.